mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.003 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |